Overview of stobadine bioanalysis: Evaluation and application in pharmacokinetics

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 3, 1999, Pages 237-242

  Bauerová, Katarína ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Antioxidant; Bioassay; GC; GC MS; HPLC; Liquid liquid extraction; Pharmacokinetics; Radiometry; Solid phase extraction; Spectrofluorometry; Stobadine; TLRC; Toxicokinetics

Indexed keywords

ANTIARRHYTHMIC AGENT; DRUG METABOLITE; STOBADINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOASSAY; BIOEQUIVALENCE; DOG; DRUG BLOOD LEVEL; DRUG URINE LEVEL; HUMAN; LIQUID SCINTILLATION COUNTING; NONHUMAN; PLASMA; RAT; SPECTROFLUOROMETRY;

EID: 0033400902     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190026     Document Type: Article

References (20)

1. Stolc S., Bauer V., Benes L., Tichy Z. (1983) : Medicine with antiarrhythmic and antihypoxic activity and its method of preparation. Patents: CS 229067, SWED. 8204693-9, BELG. 894148, SWISS 651754, BRD P-3231088, SPAIN 553017, JAP. 1514040.
2. Horáková L'., Stolc S. (1998) : Review: antioxidant and pharmacodynamic effects of pyridoindole stobadine. Gen. Pharmacol., 30: 627-638.
3. Stefek M., Benes L'., Jergelová M., Scasnár V., Turi-Nagy L., Kocis P. (1987) : Biotransformation of stobadine, a γ-carboline antiarrhythmic and cardioprotective agent, in rat liver microsomes. Xenobiotica, 17: 1067-1073.
4. 3H]-stobadine in biological material. J. Radioanal. Nucl. Chem., 111: 117-122.
5. Kállay Z., Bittererová J., Brejcha A., Fáberová V., Bezek S., Trnovec T. (1990) : Plasma concentration, tissue distribution and excretion of the prospective cardioprotective agent cis-(-)-2,3,4,4a,5,9b-hexahydro-2,8-dimethyl-1H-pyrido-[4,3b-b]indole dihydrochloride in rats. Arzneimittelforschung., 40: 974-979.
6. Kállay Z., Soltés L., Trnovec T. (1991) : Pharmacokinetics of stobadin and of the sum of its metabolites in rats during repeated administration. Biopharm. Drug Dispos., 12: 201-205.
7. Ujházy E., Fáberová V., Zemánek M., Dubovicky M., Jansák J. (1993) : Maternal-fetal distribution of stobadine in rabbits. Teratology, 48: 40.
8. Ujházy E., Fáberová V., Dubovický M. et al. (1995) : Placental transfer of stobadine at different gestational stages in rabbits - approximation by pharmacokinetic model [in Slovak]. Cs. Fyziol., 44: 15-17
9. Kristofová A., Ujházy E., Bezek S., Balónová T., Nosál' R. (1991) : Stobadine toxicity and transplacental movement. Arch. Toxicol., 14 (Suppl): 280-284.
10. Scasnár V., Bezek S., Trnovec T. (1989) : Fluorimetric assay of stobadine in serum of dogs. J. Pharm. Biomed. Anal., 7: 1207-1212.
11. Marko V. (1985) : Spectrofluorometric analysis in biological fluids of the dihydrochloride of (-)-cis-2,8-dimethyl-2,3,4,4a,5,9b-hexahydro-1-H-pyrido[4,3b]-indole (DH 1011), a prospective antiarrythmic. Pharmazie, 40: 192.
12. Bezek S., Scasnár V., Durisová M., Trnovec T., Kukan M. (1988) : Stobadine bioavailability in dogs [in Slovak]. Cs. Fyziol., 37: 240.
13. Majerčík M., Babinská M., Ujházy E., Babulová A., Balónová T. (1984) : Six-month toxicology study of the substance DP 1031 in beagle dogs [in Slovak]. Cs. Fyziol., 33: 171.
14. Soltés L., Kállay Z., Bezek S., Fedelesová V. (1991) : A high-performance liquid chromatographic method for the determination of stobadin pharmacokinetics in serum. Biopharm. Drug Dispos., 12: 29-35.
15. 3H-labelled stobadin in rat plasma for pharmacokinetic purposes. Pharmazie, 45: 437-438.
16. Marko V. (1988) : Determination of stobadine, a novel cardioprotective drug, using capillary gas chromatography with nitrogen-phosphorus detection after selective solid-phase extraction from serum. J. Chromatogr., 433: 269-275.
17. Bauerová K., Bezek S., Bohov P., Ďurišová M., Kukan M. (1995) : Evaluation of relative bioavailability of two stobadine preparations in dogs. Ther. Drug Monit., 17: 423.
18. Koprda V., Mihalová D., Bohácik L'. (1998) : The effect of Azone on penetration of pyridoindole acylderivatives across 5-day-rat skin. Proc. 6th International Conference: Perspectives in Percutaneous Penetration, Leiden, The Netherlands, September 22-26 1998, Vol. 6A, 29-31.
19. Marko V., Soltés L., Radová K. (1990) : Polar interactions in solid-phase extraction of basic drugs by octadecylsilanized silica. J. Chromatogr. Sci., 18: 403-406.
20. Marko V., Soltés L., Novák I. (1990) : Selective solid-phase extraction of basic drugs by C18-silica. Discussion of possible interactions. J. Pharm. Biomed. Anal., 8: 297-301